{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:14:57Z","timestamp":1787613297845,"version":"build-2736575974"},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011284","name":"Valeant Pharmaceuticals International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011284","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Podiatric Medicine and Surgery"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.cpm.2019.12.015","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T17:40:45Z","timestamp":1583430045000},"page":"401-407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy and Safety of Efinaconazole 10% Solution in\u00a0the Treatment of Onychomycosis in\u00a0Diabetic Patients"],"prefix":"10.1016","volume":"37","author":[{"given":"David","family":"Shofler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz","family":"Hamedani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Seun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Navarrete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Thamby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Harkless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpm.2019.12.015_bib1","series-title":"National diabetes statistics report: estimates of diabetes and its burden in the United States","year":"2017"},{"key":"10.1016\/j.cpm.2019.12.015_bib2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1365-2133.1998.02464.x","article-title":"Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicenter study","volume":"139","author":"Gupta","year":"1998","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.cpm.2019.12.015_bib3","first-page":"379","article-title":"The prevalence and management of onychomycosis in diabetic patients","volume":"10","author":"Gupta","year":"2000","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.cpm.2019.12.015_bib4","first-page":"887","article-title":"Patient considerations in the management of toe onychomycosis - role of efinaconazole","volume":"9","author":"LaSenna","year":"2015","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"10.1016\/j.cpm.2019.12.015_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.diabres.2010.09.016","article-title":"Chronic interdigital dermatophytic infection: a common lesion associated with potentially severe consequences","volume":"91","author":"Vanhooteghem","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.cpm.2019.12.015_bib6","first-page":"1","article-title":"Efinaconazole: a new topical treatment for onychomycosis","volume":"19","author":"Gupta","year":"2014","journal-title":"Skin Therapy Lett"},{"issue":"5","key":"10.1016\/j.cpm.2019.12.015_bib7","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1128\/AAC.02063-12","article-title":"Mechanism of action of efinaconazole, a novel triazole antifungal agent","volume":"57","author":"Tatsumi","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.cpm.2019.12.015_bib8","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jaad.2012.10.013","article-title":"Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies","volume":"68","author":"Elewski","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.cpm.2019.12.015_bib9","first-page":"1186","article-title":"Efinaconazole topical, 10% for the treatment of toenail onychomycosis in patients with diabetes","volume":"13","author":"Vlahovic","year":"2014","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"3","key":"10.1016\/j.cpm.2019.12.015_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7547\/0970195","article-title":"Ciclopirox 8% nail lacquer topical solution for the treatment of onychomycosis in subjects with diabetes: a multicenter, open-label study","volume":"97","author":"Brenner","year":"2007","journal-title":"J\u00a0Am Podiatr Med Assoc"},{"issue":"3","key":"10.1016\/j.cpm.2019.12.015_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/14764172.2018.1502451","article-title":"Efficacy of combination therapy with efinaconazole 10% solution and 1064\u00a0nm Nd:YAG laser for treatment of toenail onychomycosis","volume":"21","author":"Bonhert","year":"2019","journal-title":"J\u00a0Cosmet Laser Ther"},{"issue":"1","key":"10.1016\/j.cpm.2019.12.015_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000488369","article-title":"Single-center, prospective, blinded study comparing the efficacy and compatibility of efinaconazole 10% solution in treating onychomycosis with and without concurrent nail polish use","volume":"5","author":"Canavan","year":"2018","journal-title":"Skin Appendage Disord"},{"issue":"4","key":"10.1016\/j.cpm.2019.12.015_bib13","first-page":"286","article-title":"Efinaconazole solution 10% for treatment of toenail onychomycosis in Latino patients","volume":"99","author":"Cook-Bolden","year":"2017","journal-title":"Cutis"}],"container-title":["Clinics in Podiatric Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891842219301107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891842219301107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:58:54Z","timestamp":1760209134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891842219301107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0891842219301107"],"URL":"https:\/\/doi.org\/10.1016\/j.cpm.2019.12.015","relation":{},"ISSN":["0891-8422"],"issn-type":[{"value":"0891-8422","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Efinaconazole 10% Solution in\u00a0the Treatment of Onychomycosis in\u00a0Diabetic Patients","name":"articletitle","label":"Article Title"},{"value":"Clinics in Podiatric Medicine and Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpm.2019.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}